Trends & Perspectives

Published: January 1, 2008
Find more content on:
Strong growth projected for POC products

By: Richard Park

 

 

 

 

 

The potential growth of the point-of-care (POC) diagnostics market during the next five years is discussed in “Worldwide Market and Emerging Technologies for Point-of-Care Testing,” a report published by InteLab Corp. (Mission Viejo, CA). The study highlighted the individual sectors in the international POC market, such as hospital bedside, home/self-testing, and physician's office lab (POL), and the factors affecting its development.

The report indicates the overall POC industry will expand by 10.4%, with some individual sectors growing in excess of this forecast. In 2005, the POC market controlled roughly 35% of the total diagnostics product market, and projections indicate that by 2011, it will maintain 41% of the market.

Customer demands for improved patient outcomes and reduced healthcare costs are crucial factors influencing the POC industry's growth potential. However, the most important issue affecting the POC testing market's progress is the demand for care delivery outside of a hospital setting. Home/self-testing products comprise the majority of the IVD products market, followed by tests performed in physicians' offices or at hospital bedsides. In the home/ self-testing sector, which will see a 10.6% increase from 2006 to 2011, roughly 98% of the tests performed were whole blood glucose tests taken by diabetics.

Sales of hospital critical care products and POL tests will grow at an 11.7% compound annual rate by 2011. The increase will be the result of immunoassay expansion and the adoption of more molecular diagnostics in the POL sector, which includes labs ranging from small, sole-practitioner-operated units to large operations serving group practices. The POL product increase will net $2.64 billion by 2011, up from $1.66 billion in 2005.

Hospital emergency departments, operating rooms, and intermediate care wards comprise the hospital bedside testing sector, which forecasts a 6% increase by 2011. The combined market for hospital bedside POC testing products totaled $1.3 billion in 2005, and is forecast to grow to $2.6 billion by 2011.

Additional information about this study and market supplier data can be accessed at InteLab Corp.'s Web site at www.intelabcorp.com.

Copyright ©2008 IVD Technology

 


No votes yet